These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21233809)

  • 41. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women.
    Peppa M; Koliaki C; Papaefstathiou A; Garoflos E; Katsilambros N; Raptis SA; Hadjidakis DI; Dimitriadis GD
    Obesity (Silver Spring); 2013 Sep; 21(9):1807-14. PubMed ID: 23696298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does metabolic health in overweight and obesity persist? - Individual variation and cardiovascular mortality over two decades.
    Kaur A; Johnston DG; Godsland IF
    Eur J Endocrinol; 2016 Aug; 175(2):133-43. PubMed ID: 27412654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obesity, cardiovascular risk, and lifestyle: cross-sectional and prospective analyses in a nationwide Spanish cohort.
    Valenzuela PL; Santos-Lozano A; Saco-Ledo G; Castillo-García A; Lucia A
    Eur J Prev Cardiol; 2023 Oct; 30(14):1493-1501. PubMed ID: 37317985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women.
    Kabat GC; Wu WY; Bea JW; Chen C; Qi L; Stefanick ML; Chlebowski RT; Lane DS; Wactawski-Wende J; Wassertheil-Smoller S; Rohan TE
    Int J Obes (Lond); 2017 Jan; 41(1):170-177. PubMed ID: 27748744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay.
    Ronco AL; De Stefani E; Deneo-Pellegrini H; Quarneti A
    Asian Pac J Cancer Prev; 2012; 13(1):139-46. PubMed ID: 22502657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women.
    Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y
    J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events.
    Campello E; Zabeo E; Radu CM; Spiezia L; Gavasso S; Fadin M; Woodhams B; Vettor R; Simioni P
    Thromb Haemost; 2015 Jan; 113(1):85-96. PubMed ID: 25318550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype.
    Phillips CM; Tierney AC; Perez-Martinez P; Defoort C; Blaak EE; Gjelstad IM; Lopez-Miranda J; Kiec-Klimczak M; Malczewska-Malec M; Drevon CA; Hall W; Lovegrove JA; Karlstrom B; Risérus U; Roche HM
    Obesity (Silver Spring); 2013 Jan; 21(1):E154-61. PubMed ID: 23505198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study.
    Baldassarre S; Fragapani S; Panero A; Fedele D; Pinach S; Lucchiari M; Vitale AR; Mengozzi G; Gruden G; Bruno G
    Cardiovasc Diabetol; 2017 Sep; 16(1):119. PubMed ID: 28946871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
    Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
    Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aerobic training improved low-grade inflammation in obese women with intellectual disability.
    Ordonez FJ; Rosety MA; Camacho A; Rosety I; Diaz AJ; Fornieles G; Garcia N; Rosety-Rodriguez M
    J Intellect Disabil Res; 2014 Jun; 58(6):583-90. PubMed ID: 23742222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Interleukin 6(Il-6), Tumor Necrosis Factor Alpha (Tnf-α) and Paraoxonase 1(Pon 1) in Obese and Non-Obese Metabolic Syndrome.
    Samy K; Porwal YC; Yadav A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
    Voulgari C; Tentolouris N; Dilaveris P; Tousoulis D; Katsilambros N; Stefanadis C
    J Am Coll Cardiol; 2011 Sep; 58(13):1343-50. PubMed ID: 21920263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benefits of Regular Exercise on Inflammatory and Cardiovascular Risk Markers in Normal Weight, Overweight and Obese Adults.
    Gondim OS; de Camargo VT; Gutierrez FA; Martins PF; Passos ME; Momesso CM; Santos VC; Gorjão R; Pithon-Curi TC; Cury-Boaventura MF
    PLoS One; 2015; 10(10):e0140596. PubMed ID: 26474157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer risk in metabolically healthy but overweight postmenopausal women.
    Gunter MJ; Xie X; Xue X; Kabat GC; Rohan TE; Wassertheil-Smoller S; Ho GY; Wylie-Rosett J; Greco T; Yu H; Beasley J; Strickler HD
    Cancer Res; 2015 Jan; 75(2):270-4. PubMed ID: 25593034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell adhesion molecules and plasminogen activator inhibitor type-1 (PAI-1) in patients with rheumatoid arthritis: influence of metabolic syndrome.
    de Sá MC; Simão ANC; de Medeiros FA; Iriyoda TMV; Costa NT; Alfieri DF; Flauzino T; Sekiguchi BA; Lozovoy MAB; Reiche EMV; Maes M; Dichi I
    Clin Exp Med; 2018 Nov; 18(4):495-504. PubMed ID: 30008151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.
    Song Y; Manson JE; Tinker L; Rifai N; Cook NR; Hu FB; Hotamisligil GS; Ridker PM; Rodriguez BL; Margolis KL; Oberman A; Liu S
    Diabetes; 2007 Jul; 56(7):1898-904. PubMed ID: 17389327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic disease and adverse events from immune checkpoint inhibitors.
    Leiter A; Carroll E; De Alwis S; Brooks D; Shimol JB; Eisenberg E; Wisnivesky JP; Galsky MD; Gallagher EJ
    Eur J Endocrinol; 2021 Jun; 184(6):857-865. PubMed ID: 34552304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Body Mass Index at Accession and Incident Cardiometabolic Risk Factors in US Army Soldiers, 2001-2011.
    Hruby A; Bulathsinhala L; McKinnon CJ; Hill OT; Montain SJ; Young AJ; Smith TJ
    PLoS One; 2017; 12(1):e0170144. PubMed ID: 28095509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.